http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_26c8ba19d39b12f900de0db8753751a2
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Xu |
| name | Shuichan Xu |
| given-name | Shuichan |
| organization-name | Oncology Research, Celgene Corporation, San Diego, CA 92121, USA 1Celgene Corporation, San Diego, California. Celgene Corporation San Diego California Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas 75235-9041 Bristol Myers Squibb, 10300 Campus Point Drive, Suite 100, San Diego, California 92121, United States Authors' Affiliations: 1Laboratory of Molecular Pathology, Ludwig Institute for Cancer Research; 2Moores Cancer Center; 3University of California San Diego, La Jolla; 4Celgene Corporation, San Diego; 5Department of Neurological Surgery and Brain Tumor Research Center, University of California at San Francisco, San Francisco; 6California Institute of Technology, Pasadena; 7Henry Singleton Brain Tumor Program; 8Jonsson Comprehensive Cancer Center; 9Department of Neurology, David Geffen UCLA School of Medicine; 10Department of Molecular and Medical Pharmacology; 11UCLA Medical Scientist Training Program, University of California, Los Angeles, Los Angeles, California; 12Celgene Corporation, Summit, New Jersey; 13Department of Radiation Oncology, Ohio State University Comprehensive Cancer Center and Arthur G. James Cancer Hospital, Columbus, Ohio; 14Department of Neurological, Neuropsychological, Morphological and Movement Sciences, University of Verona, Verona, Italy; 15INSERM; 16Metabolomics Platform, Institut Celgene Corporation, San Diego, California, USA. Signal Pharmaceuticals, LLC, San Diego, California 92121 1Department of Oncology Research, Celgene Corporation, San Diego, California. |
Incoming Links
Total number of triples: 36.